Verapamil in Acute Myocardial Infarction. The Rationales of the VAMI and DAVIT III Trials

Abstract

Verapamil is well tolerated in patients with stable and unstable angina pectoris, as well as in patients with threatened infarction. No data exist documenting verapamil to be inferior to beta-blockers in these stages of coronary heart diseases. In the prethrombolytic era i.v. intervention with verapamil did not add any benefit in the early phase of AMI… (More)
DOI: 10.1023/A:1007751231224

Topics

9 Figures and Tables

Slides referencing similar topics